Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000676228 | SCV000251271 | uncertain significance | not provided | 2018-11-16 | criteria provided, single submitter | clinical testing | A variant of unknown significance has been identified in the COQ6 gene. The D132G (c.395 A>G) variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The D132G missense change is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. In silico analysis is inconsistent in its predictions as to whether or not the D132G variant is damaging to the protein structure/function. Several in silico splice prediction models predict that the c.395 A>G nucleotide substitution, responsible for D132G, creates a cryptic donor site which may supplant the natural donor site and lead to abnormal gene splicing. However, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. Therefore, based on the currently available information, it is unclear whether the D132G (c.395 A>G) variant is a pathogenic mutation or a rare benign variant.0 |
Mayo Clinic Laboratories, |
RCV000676228 | SCV000801982 | uncertain significance | not provided | 2023-06-16 | criteria provided, single submitter | clinical testing | BS1, PP3 |
Invitae | RCV000676228 | SCV001023795 | likely benign | not provided | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003937730 | SCV004750848 | likely benign | COQ6-related condition | 2020-09-21 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |